Search Results - COVIDsortium Investigators
- Showing 1 - 2 results of 2
-
1
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity by Daniel M. Altmann, Catherine J. Reynolds, George Joy, Ashley D. Otter, Joseph M. Gibbons, Corinna Pade, Leo Swadling, Mala K. Maini, Tim Brooks, Amanda Semper, Áine McKnight, Mahdad Noursadeghi, Charlotte Manisty, Thomas A. Treibel, James C. Moon, COVIDsortium investigators, Rosemary J. Boyton
Published in Nature Communications (2023-08-01)Get full text
Article -
2
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity. by Peter A C Wing, Nathalie M Schmidt, Rory Peters, Maximilian Erdmann, Rachel Brown, Hao Wang, Leo Swadling, COVIDsortium Investigators, Joseph Newman, Nazia Thakur, Kaho Shionoya, Sophie B Morgan, Timothy Sc Hinks, Koichi Watashi, Dalan Bailey, Scott B Hansen, Andrew D Davidson, Mala K Maini, Jane A McKeating
Published in PLoS Pathogens (2023-05-01)Get full text
Article
